IJCCR_2024v14n2

International Journal of Clinical Case Reports 2024, Vol.14, No.2, 66-78 http://medscipublisher.com/index.php/ijccr 67 enhances the potential of SynComs by enabling the analysis and optimization of complex microbial interactions (Kumar et al., 2022). The primary objective of this study is to evaluate the current advancements and potential of engineering synthetic microbial communities for enhanced probiotic functionality and gut health improvement. This study aims to synthesize existing research on SynComs, identify the key factors influencing their design and efficacy, and highlight the potential benefits and challenges associated with their use. By providing a comprehensive overview of the state-of-the-art in SynCom engineering, this study seeks to offer valuable insights for researchers, clinicians, and industry stakeholders. Ultimately, the significance of this study lies in its potential to guide future research and development efforts towards creating more effective probiotic therapies that can address the complexities of gut health and contribute to overall well-being. 1 Gut Microbiota and Probiotic Functionality 1.1 Composition and functions of the gut microbiota The human gut microbiota is a diverse and dynamic community of microorganisms, including bacteria, archaea, viruses, and fungi. These microorganisms are crucial for various physiological functions such as digestion, nutrient absorption, and immune modulation. The gut microbiota composition varies between individuals and can be influenced by diet, environment, and genetics (Kho and Lal, 2018)., which collectively shape its structure and function (Vrancken et al., 2019). Understanding the intricate interactions within this microbial community is essential for developing effective therapeutic strategies aimed at modulating gut health. 1.2 Mechanisms through which probiotics influence gut health Probiotics, defined as live microorganisms that confer health benefits to the host when administered in adequate amounts, exert their effects through multiple mechanisms. They enhance the gut barrier function, modulate the immune response, and inhibit pathogenic bacteria by producing antimicrobial substances (Kaur and Ali, 2022). Probiotics also produce short-chain fatty acids (SCFAs) like butyrate, which provide energy to colonocytes and exhibit anti-inflammatory properties (Satapathy et al., 2019). Advances in synthetic biology have enabled the engineering of probiotics to enhance these functionalities further. For instance, engineered probiotics can be designed to produce and deliver therapeutic molecules directly within the gut, thereby improving their efficacy in treating various gastrointestinal disorders (Dou and Bennett, 2018; Kumar et al., 2022). 1.3 Limitations of current probiotic formulations Despite the promising potential of probiotics, current formulations face several limitations. Traditional probiotics often lack the complexity and adaptability of the native gut microbiota, which can limit their effectiveness in restoring or maintaining gut health (Dou and Bennett, 2018). Many probiotics struggle to survive the acidic environment of the stomach and bile salts in the intestine (Zhou et al., 2020), the stability and viability of probiotic strains during storage and gastrointestinal transit remain significant challenges (Martins et al., 2023). Synthetic microbial communities (SynComs) offer a potential solution by combining multiple microbial species to create a more stable and functional consortium. However, ensuring the long-term stability and colonization of these synthetic communities in the gut environment is still a major hurdle (Berkhout et al., 2022; Martins et al., 2023). Further research is needed to address these challenges and optimize the design and application of engineered probiotics and SynComs for improved gut health outcomes. 2 Engineering Synthetic Microbial Communities (SynComs) 2.1 Definition and principles of SynComs Synthetic microbial communities (SynComs) are deliberately constructed consortia of microorganisms designed to perform specific functions within a host environment. Unlike natural microbial communities, which are complex and often unpredictable, SynComs are composed of carefully selected microbial species that are engineered to achieve desired outcomes, such as enhancing gut health or providing therapeutic benefits (van Leeuwen et al., 2023; Martins et al. 2023). The goal is to create a stable, resilient, and functional microbiome that can outcompete pathogenic bacteria and provide health benefits to the host. The principles underlying SynComs involve

RkJQdWJsaXNoZXIy MjQ4ODYzNQ==